Drug
P005672
P005672: highest development phase Phase 2, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| 50 mg P005672-HCl NCT01628549 | Phase 2 | Acne Vulgaris |
Latest
No recent events.
Follow P005672 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.